NCT06974292View on ClinicalTrials.gov

The Mass Balance and Biotransformation Study of [14C] VC005 in Chinese Healthy Adult Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

May 26, 2025

Primary Completion Date

June 3, 2025

Study Completion Date

June 3, 2025

Conditions
Atopic Dermatitis
Interventions
DRUG

[14C]VC005

Take a suspension of 50 mg VC005 ,containing about 120 μCi \[14C\]VC005, in fasting within 5 minutes

Trial Locations (1)

Unknown

The First Affiliated Hospital of Suzhou University, Suzhou

All Listed Sponsors
lead

Jiangsu vcare pharmaceutical technology co., LTD

INDUSTRY

NCT06974292 - The Mass Balance and Biotransformation Study of [14C] VC005 in Chinese Healthy Adult Male Volunteers | Biotech Hunter | Biotech Hunter